Explore the debate over regulatory data protection in India, its impact on pharmaceutical research, and how it balances intellectual property rights with access to medicines. Learn about India’s approach and its implications for the generic industry.
Read more about Pharmaceutical Regulatory Data Protection in IndiaTag: generics
Pharmaceutical Business Strategy – A Generics Perspective
This article examines the strategy of generic drug companies in challenging pharmaceutical patents, focusing on Paragraph IV certifications and related litigation. It highlights trends, success rates, and the increasing participation of Indian companies in the US generics market.
Read more about Pharmaceutical Business Strategy – A Generics Perspective